Showing results (91-100 of 190) with videos related to
Sort By:
Pageof 19
Thyroid : Official Journal of the American Thyroid Association|January 11, 2017
Patterns of Treatment Failure in Anaplastic Thyroid CarcinomaSarika N Rao, Mark Zafereo, Ramona Dadu, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 1, 2019
Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trialG Brandon Gunn, Tito R Mendoza, Adam S Garden, et al.Clinical Pharmacology and Therapeutics|April 24, 2014
Inflammation-related genetic variations and survival in patients with advanced non-small cell lung cancer receiving first-line chemotherapyXia Pu, Michelle A Hildebrandt, Charles Lu, et al.Oncotarget|October 4, 2018
Outcome analysis of Phase I trial patients with metastatic <i>KRAS</i> and/or <i>TP53</i> mutant non-small cell lung cancerYudong Wang, Zhijie Wang, Sarina Piha-Paul, et al.Plos One|September 3, 2010
Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancerMichelle A T Hildebrandt, Ritsuko Komaki, Zhongxing Liao, et al.Thyroid : Official Journal of the American Thyroid Association|June 1, 2013
Randomized safety and efficacy study of fosbretabulin with paclitaxel/carboplatin against anaplastic thyroid carcinomaJulie A Sosa, Rossella Elisei, Barbara Jarzab, et al.The New England Journal of Medicine|June 10, 2010
Human papillomavirus and survival of patients with oropharyngeal cancerK Kian Ang, Jonathan Harris, Richard Wheeler, et al.JAMA Oncology|October 24, 2024
Anti-Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical TrialMaria E Cabanillas, Ramona Dadu, Renata Ferrarotto, et al.Nature Cancer|July 15, 2024
Building a translational cancer dependency map for The Cancer Genome AtlasXu Shi, Christos Gekas, Daniel Verduzco, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesotheliomaCharles Lu, Roman Perez-Soler, Bilal Piperdi, et al.Pageof 19